Overview
- ARK bought 7,737 shares of Tempus AI on Jan. 26 across ARKK and ARKG, a purchase valued at about $505,380 according to the day’s trade report.
- Autonomous-vehicle exposure increased through ARKQ with 48,260 WeRide shares acquired for roughly $425,653 and 47,752 Kodiak AI shares for about $447,913.
- Biotech holdings were reduced the same day, including sales of 64,695 Twist Bioscience shares worth approximately $2.78 million and 67,086 10x Genomics shares worth about $1.50 million.
- Additional adjustments included buying 27,830 Bullish shares for roughly $994,922 and selling 3,902 Kratos Defense shares valued near $430,741.
- The moves extend a multi-day rotation that followed large Friday additions in Tempus AI and WeRide, underscoring ARK’s tilt toward AI-driven healthcare and self-driving technology.